Literature DB >> 15618006

The Hodgkin and Reed/Sternberg cell.

Ralf Küppers1, Martin-Leo Hansmann.   

Abstract

Hodgkin and Reed/Sternberg (HRS) cells are the hallmark cells of Hodgkin's lymphoma (HL). They are large, often multinucleated with a peculiar morphology and an unusual immunophenotype, that does not resemble any normal cell in the body. Despite their rarity in HL tissues, HRS cells are the clonal tumour cells of HL. HRS cells in nearly all cases of HL derive from B cells, and only rarely from T cells. Notably, the pattern of somatic mutations in their rearranged immunoglobulin V genes suggests that they are derived from pre-apoptotic germinal center B cells. The pathogenesis of HL is still largely unresolved, but it is now clear that aberrant activation of several signalling pathways (such as the NFkappaB pathway) is of key importance for HRS cell survival. HRS or HRS-like cells are also found in several other diseases, e.g. as rare intermingled cells in some non-Hodgkin lymphomas and in infectious mononucleosis.

Entities:  

Mesh:

Year:  2005        PMID: 15618006     DOI: 10.1016/j.biocel.2003.10.025

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

1.  Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.

Authors:  Andrés E Quesada; Binara Assylbekova; Christine E Jabcuga; Rongzhen Zhang; Michael Covinsky; Adan Rios; Nghia D Nguyen; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

3.  MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.

Authors:  Kui Nie; Mario Gomez; Pablo Landgraf; Jose-Francisco Garcia; Yifang Liu; Leonard H C Tan; Amy Chadburn; Thomas Tuschl; Daniel M Knowles; Wayne Tam
Journal:  Am J Pathol       Date:  2008-07       Impact factor: 4.307

Review 4.  Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

Authors:  G Kapatai; P Murray
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

Review 5.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

6.  Cell fusion in tumor progression: the isolation of cell fusion products by physical methods.

Authors:  Filippo Pedrazzoli; Iraklis Chrysantzas; Luca Dezzani; Vittorio Rosti; Massimo Vincitorio; Giammaria Sitar
Journal:  Cancer Cell Int       Date:  2011-09-20       Impact factor: 5.722

7.  Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by acyclovir.

Authors:  Richard E Kast
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

8.  Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH).

Authors:  H Besson; P Brennan; N Becker; S De Sanjosé; A Nieters; R Font; M Maynadié; L Foretova; P L Cocco; A Staines; M Vornanen; P Boffetta
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

9.  Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.

Authors:  Ágnes Márk; Melinda Hajdu; Zsófia Váradi; Tamás Béla Sticz; Noémi Nagy; Judit Csomor; Lajos Berczi; Viktória Varga; Monika Csóka; László Kopper; Anna Sebestyén
Journal:  BMC Cancer       Date:  2013-05-22       Impact factor: 4.430

10.  Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.

Authors:  Faisal M Fadlelmola; Minglong Zhou; Ronald J de Leeuw; Nirpjit S Dosanjh; Karynn Harmer; David Huntsman; Wan L Lam; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2008-01-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.